INPUD (the International Network of People who Use Drugs) and ANPUD (the Asian Network of People who Use Drugs) urgently request a halt be called on the killing of people who use drugs in the Philippines. We implore Your Excellency President Duterte to reconsider the current approach of executing people who use drugs in favour of internationally accepted, evidence-based alternatives.
Retain the naming of key populations, including transgender
people, consistently throughout all relevant sections in the
2016 Political Declaration, especially in paragraphs
that outline strategies and responses.
Commit to a roadmap towards decriminalization
of key populations and removing age restrictions and
parental and marital consent requirements for
adolescents and young people.
Ensure universal access to comprehensive
harm reduction, sexual and reproductive health
and rights, HIV information services and
comprehensive sexuality education for all.
Establish a robust and systematic assessment
of how countries fulfill its human rights
obligations, including the right to health,
especially for key populations and women
Develop sustainable mechanisms to ensure the
availability, affordability and accessibility of
treatment and diagnostics for HIV, TB, Hep-C
and other co-infections in ALL low and
Utilize all TRIPS flexibilities to prevent evergreening and
other patent rights abuses that curtail access to medicines,
diagnostics and vaccines. LDCs should use the TRIPS
transition to 2021 and phamaceticals transition to 2033
and suspend IP barriers on generic medicines
Remove TRIPS-plus provisions that negatively
impact production of generic medicines; and
remove all TRIPS-plus demands from the
Regional Comprehensive Economic
We believe that all services both prevention & treatment for all people who use drugs, irrespective of age or gender, must be acceptable, accessible, compassionate, comprehensive, evidence-based and voluntary.
Recovering Nepal, National network of Drug Users and Drug led organizations (RN), conducted Protest against program of disseminating "Hepatitis Treatment Guideline for Nepal". Protest against Technical Team, in-front health Minister to ensure inclusion of drug user's community and key technical activist of civil society in Nepal.
Protest was a success: Technical team conceptually agreed to revisit the process and minister also reinforced to address the voices of Civil Society.
WHO, UNAIDS and UNODC guidelines setting targets for national governments for universal access to HIV prevention, care and support include treatment for HCV and hepatitis B virus as part of the comprehensive package of services for PWID,14 but countries are unable to implement these treatments at scale because of their expense.
It is against this background that ANPUD embarked on this project, to begin to investigate and document the barriers to diagnosis, management and treatment of HCV amongst PWID. Four countries were chosen for the pilot study: India, Indonesia, Nepal and Malaysia, as being representative of these wide and varied regions.
This investigation and documentation provides some of the necessary foundations for the next steps, in which ANPUD will develop a regional hepatitis C advocacy strategy based on the study findings. These findings will help ensure that this strategy addresses the key issues in a prioritised manner, responding to and being driven by the needs of the community.
The high-level meeting on HIV/AIDS, to be held in June 2016 by the General Assembly is a pivotal occasion to rally global commitment to the fast-track targets and core actions for ending AIDS by 2030, as outlined in the UNAIDS 2016-2021 Strategy, “On the Fast-Track to end AIDS”.
Civil society networks and their member organizations across the Asia and the Pacific region has come up with this Asia-Pacific civil society position statement entitled 'Ending AIDS in 2030: Do not Leave ASIA-PACIFIC Behind' as an integrated and unified voices representing all the key populations most vulnerable and affected by HIV/AIDS. In order to turn the wheel of High Level Meeting and make it a historic event, our region has developed key advocacy messages also termed as 'Asks to the member states at this UN High Level Meeting on Ending AIDS'.
WHO updated its hepatitis C treatment guidelines to provide recommendations for the use of these new medicines. The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014.
Mr. Charanjit Sharma, from Manipur in North-East India, is the secretary of the Indian Drug Users Forum (IDUF). He is also involved with the India HIV/AIDS Alliance.
Being recently selected as a Civil Society Speaker out of 257 applicants, he, with his grassroot experiences, represented drug user community and addressed our issues at the United Nations General Assembly Special Session (UNGASS) on the World Drug Problem held during 19-21 April 2016 at the United Nations Headquarters in New York. He spoke in the 6th plenary along with 4 other Civil Society speakers from different parts of the world.
The verbatim script of his speech and video is published. Please go to time 2:28:50 to directly watch Mr. Charan's speech.